NCT06843551: An ongoing trial by Benjamin Spieler
This trial is ongoing. It must report results 5 years, 6 months from now.
Full data
| Full entry on ClinicalTrials.gov | NCT06843551 |
|---|---|
| Title | A Phase 2 Single Arm Trial of Stereotactic Body Radiation Therapy Followed by Dual Immune Checkpoint Inhibition for Patients With Metastatic Pancreatic Ductal Adenocarcinoma - The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 18, 2025 |
| Completion date | Aug. 1, 2030 |
| Required reporting date | Aug. 1, 2031, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 28, 2026 |
| Days late | None |